Entrada Therapeutics Inc.
12.84
0.35 (2.80%)
At close: Jan 15, 2025, 10:26 AM

Entrada Therapeutics Inc. Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for TRDA stock have an median target of 28, with a low estimate of 20 and a high estimate of 29. The median target predicts an increase of 118.07% from the current stock price of 12.84.

Analyst Consensus: Buy
Target Low Average Median High
Price $20 $25.67 $28 $29
Change 55.76% 99.92% 118.07% 125.86%

AI Analyst Report

HC Wainwright & Co. maintains a Buy rating on Entr... Unlock content with Pro Subscription

Updated Nov 06, 2024

Rating Mar 24Jun 24Aug 24Nov 24Dec 24
Strong Buy 00010
Buy 11211
Hold 00000
Sell 00000
Strong Sell 00000
Total 1 1 2 2 1

Financial Forecast this Year

Revenue This Year
186.51M
from 129.01M
Increased by 44.6%
Revenue Next Year
46.74M
from 186.51M
Increased by -74.9%
EPS This Year
1.05
from -0.2
Increased by -425%
EPS Next Year
-3.09
from 1.05
Increased by -194.3%